Global Peptide Synthesizers Market Growth 2023-2029
Peptide Synthesizers: Laboratory automated peptide synthesizers typically belong to one of two categories: small scale, high throughput parallel and larger scale batch synthesizers. Most small scale, high throughput parallel peptide synthesizers can utilize at most one to two hundred milligrams of resin in each reactor, but can process tens to hundreds of reactors simultaneously. Many of these peptide synthesizers utilize X-Y robotics equipped with syringe pumps to precisely deliver amino acid and reagent solutions to individual reactors.
Batch peptide synthesizers utilize larger scale reactors, even up to 500 ml to 1000 ml, capable of handling up to a hundred grams of resin in one reactor. These synthesizers typically utilize a series of valves and manifolds to deliver amino acids, reagents and wash solvents to each reactor. Simple peptide instruments may have only one or two reactors, but more complex peptide instruments may have 6, 12, or even 24 reactors. Many of these synthesizers rely on calibrated flow rates to deliver the appropriate volume of amino acid or reagent solution to the reaction vessel. Some peptide machines, such as AAPPTec’s Focus peptide synthesizers, utilize measuring vessels to accurately measure out the solution being delivered.
LPI (LP Information)' newest research report, the “Peptide Synthesizers Industry Forecast” looks at past sales and reviews total world Peptide Synthesizers sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide Synthesizers sales for 2023 through 2029. With Peptide Synthesizers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Synthesizers industry.
This Insight Report provides a comprehensive analysis of the global Peptide Synthesizers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Synthesizers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Peptide Synthesizers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Synthesizers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Synthesizers.
The global Peptide Synthesizers market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peptide Synthesizers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peptide Synthesizers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peptide Synthesizers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peptide Synthesizers players cover Bachem Holding, Thermo Fisher Scientific, Merck KGaA, GenScript Biotech, Kaneka, Biotage AB and Syngene International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Synthesizers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Solid-Phase Peptide Synthesis
Solution-Phase Peptide Synthesis
Hybrid & Recombinant Technology
Segmentation by application
Pharmaceutical & Biotechnology companies
CDMOs & CROs
Academic & Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem Holding
Thermo Fisher Scientific
Merck KGaA
GenScript Biotech
Kaneka
Biotage AB
Syngene International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Peptide Synthesizers market?
What factors are driving Peptide Synthesizers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peptide Synthesizers market opportunities vary by end market size?
How does Peptide Synthesizers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook